CN114478593A - Boron-containing organic compound and organic electroluminescent device containing same - Google Patents

Boron-containing organic compound and organic electroluminescent device containing same Download PDF

Info

Publication number
CN114478593A
CN114478593A CN202011160022.6A CN202011160022A CN114478593A CN 114478593 A CN114478593 A CN 114478593A CN 202011160022 A CN202011160022 A CN 202011160022A CN 114478593 A CN114478593 A CN 114478593A
Authority
CN
China
Prior art keywords
substituted
unsubstituted
ring
alkyl
boron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011160022.6A
Other languages
Chinese (zh)
Inventor
李熠烺
魏金贝
曾礼昌
李国孟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Eternal Material Technology Co Ltd
Original Assignee
Beijing Eternal Material Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Eternal Material Technology Co Ltd filed Critical Beijing Eternal Material Technology Co Ltd
Priority to CN202011160022.6A priority Critical patent/CN114478593A/en
Publication of CN114478593A publication Critical patent/CN114478593A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/636Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising heteroaromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1055Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • C09K2211/107Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms with other heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1074Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms
    • C09K2211/1085Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms with other heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1096Heterocyclic compounds characterised by ligands containing other heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

A boron-containing organic compound having a structure represented by (1):
Figure DDA0002742689270000011
the ring X, the ring Y and the ring Z are respectively selected from a substituted or unsubstituted 6-30-membered aromatic ring or a substituted or unsubstituted 4-30-membered aromatic heterocyclic ring; ar (Ar)1~Ar2Each selected from C6-C30 aryl, or C3-C30 heteroaryl; ra、RbAnd RnEach independently selected from hydrogen, deuterium, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, C1-C12 alkoxy, substituted or unsubstituted C3-C30 heteroaryl, and the like; and the following conditions are satisfied: at Ar1、Ar2In X and Y, Ar1A substituent being present ortho to the linking site with the N atom and ortho to the linking site of X with the N atom, or Ar2And substituents are arranged at the ortho position of the connecting position of the N atom and the ortho position of the connecting position of the Y atom and the N atom, and the substituents are selected from one of substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C12 aryl and substituted or unsubstituted C3-C12 heteroaryl.

Description

Boron-containing organic compound and organic electroluminescent device containing same
Technical Field
The invention relates to a B-N organic luminescent material, in particular to a boron-containing organic compound for an organic electroluminescent device and application thereof in the organic electroluminescent device.
Background
At present, opto-electronic devices based on organic materials are becoming more and more popular. Organic electroluminescent diodes (OLEDs), as emerging reality and lighting technologies, have many advantages such as being foldable, rollable, high resolution, self-luminescent, bright in color, low power consumption, etc.
In the field of display and illumination, the device structure of OLEDs is generally composed of functional materials such as injection materials, transport materials, and light emitting materials, and the light emitting layer is generally used by using blue (B) fluorescence in combination with red (R) and green (G) phosphorescence materials.
Recently, TADF (Thermally Activated Delayed Fluorescence) organic luminescent materials based on B-N resonance type (adv. mater.2016, 28, 2777-. Compared with phosphorescent dyes, when the compounds are doped into a main material, the compounds have the advantages of high electroluminescent efficiency, narrow spectrum, high color purity and the like, do not contain metal, and are simple to synthesize and low in price.
Disclosure of Invention
Problems to be solved by the invention
However, the conventional boron-nitrogen resonance type compound, due to the increase of the degree of conjugation thereof, is not suitable for the development of mass-produced devices because the temperature at the time of vapor deposition of the device is high and the emission color is significantly red-shifted. Therefore, there is a need to develop a material system that is favorable for evaporation of devices and has excellent chromaticity to meet the commercial requirement.
Means for solving the problems
In order to solve the above problems in the prior art, the inventors have intensively studied and found that introduction of a steric hindrance group into a specific position in a molecular skeleton can effectively reduce conjugation of a molecule, lower a sublimation temperature, and blue-shift a light color.
Specifically, the present invention provides a boron-containing organic compound characterized by having a structure represented by (1):
Figure BDA0002742689260000021
wherein, ring X, ring Y and ring Z are each independently selected from a substituted or unsubstituted 6-to 30-membered aromatic ring or a substituted or unsubstituted 4-to 30-membered aromatic heterocyclic ring, preferably a substituted or unsubstituted 6-to 8-membered aromatic ring or a substituted or unsubstituted 5-to 8-membered aromatic heterocyclic ring, more preferably a substituted or unsubstituted benzene or a substituted or unsubstituted 6-membered aromatic heterocyclic ring;
when the ring X, the ring Y or the ring Z has a substituent, the substituent is selected from one of halogen, cyano, hydroxyl, nitro, amino, substituted or unsubstituted C1 to C12 alkyl, substituted or unsubstituted C3 to C12 cycloalkyl, substituted or unsubstituted C1 to C12 alkoxy, substituted or unsubstituted C1 to C12 silyl, substituted or unsubstituted C6 to C30 arylamino, substituted or unsubstituted C3 to C30 heteroarylamino, substituted or unsubstituted C6 to C30 aryl, and substituted or unsubstituted C3 to C30 heteroaryl;
Ar1~Ar2each independently selected from one of substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 heteroaryl;
and the following conditions are satisfied:
the following conditions are satisfied:
at Ar1、Ar2In ring X and ring Y, Ar1At least one position ortho to the linking site of the N atom and ortho to the linking site of the ring X and the N atom, and/or, Ar2At least one position ortho to the linking position with the N atom and ortho to the linking position of ring Y with the N atom is substituted with one selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl;
when the substituted or unsubstituted group has a substituent, the substituent is selected from one or a combination of at least two of halogen, cyano, hydroxyl, nitro, amino, C1-C12 alkyl, C3-C12 cycloalkyl, C1-C12 alkoxy, C1-C12 silyl, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryl, and C3-C30 heteroaryl.
According to the invention, a group with a certain steric hindrance effect is introduced at the ortho position of two aromatic rings connected with a certain N atom in the formula (1), so that the conjugation of molecules can be effectively reduced, the sublimation temperature is reduced, and the light color of the material is adjusted, so that the emission wavelength of the molecules is blue-shifted. The two aromatic rings introduced with a certain group may be respectively positioned at X and Ar1In (corresponding to the left N in formula (1)), may also be located in Y and Ar, respectively2(corresponds to the right N in the formula (1)).
In the present invention, the "substituted or unsubstituted" group may be substituted with one substituent or a plurality of substituents, and when a plurality of substituents are present, different substituents may be selected from the group.
In the present specification, the expression of Ca to Cb means that the group has carbon atoms of a to b, and the carbon atoms do not generally include the carbon atoms of the substituents unless otherwise specified.
In the present specification, the expression of the "-" underlined loop structure indicates that the linking site is located at an arbitrary position on the loop structure where the linking site can form a bond.
In the present specification, "independently" means that the subject may be the same or different when a plurality of subjects are provided.
In the present invention, unless otherwise specified, the expression of a chemical element generally includes the concept of its isotope, for example, the expression "hydrogen (H)" includes the concept of its isotope 1H (protium or H), 2H (deuterium or D); carbon (C) includes 12C, 13C, etc., and will not be described again.
The hetero atom in the present invention generally refers to an atom or group of atoms selected from N, O, S, P, Si and Se, preferably N, O, S.
In the present specification, examples of the halogen include: fluorine, chlorine, bromine, iodine, and the like.
In the present invention, the monocyclic aryl group means that one or at least two phenyl groups are contained in a molecule, and when the at least two phenyl groups are contained in a molecule, the phenyl groups are independent of each other and are connected by a single bond, such as phenyl, biphenylyl, terphenylyl, and the like, for example; the fused ring aryl group means that at least two benzene rings are contained in the molecule, but the benzene rings are not independent of each other, but common ring sides are fused with each other, and exemplified by naphthyl, anthryl and the like; monocyclic heteroaryl means that the molecule contains at least one heteroaryl group, and when the molecule contains one heteroaryl group and other groups (e.g., aryl, heteroaryl, alkyl, etc.), the heteroaryl and other groups are independent of each other and are linked by a single bond, illustratively pyridine, furan, thiophene, etc.; fused ring heteroaryl refers to a fused ring of at least one phenyl group and at least one heteroaryl group, or, fused ring of at least two heteroaryl rings, illustratively quinoline, isoquinoline, benzofuran, dibenzofuran, benzothiophene, dibenzothiophene, and the like.
In the present specification, examples of the 6 to 8-membered aromatic ring include: benzene rings, and the like.
In the present specification, the aryl group includes concepts of a monocyclic aryl group and a condensed ring aryl group, and examples of the C6 to C30 aryl group include: phenyl, naphthyl, anthryl, benzanthryl, phenanthryl, benzophenanthryl, pyrenyl, anthryl, perylenyl, fluoranthenyl, tetracenyl, pentacenyl, benzopyrenyl, biphenyl, idophenyl, terphenyl, quaterphenyl, fluorenyl, spirobifluorenyl, dihydrophenanthryl, dihydropyrenyl, tetrahydropyrenyl, cis-or trans-indenofluorenyl, trimeric indenyl, isotridecylindenyl, spirotrimeric indenyl, spiroisotridecylindenyl. Specifically, the biphenyl group is selected from 2-biphenyl, 3-biphenyl, and 4-biphenyl; terphenyl includes p-terphenyl-4-yl, p-terphenyl-3-yl, p-terphenyl-2-yl, m-terphenyl-4-yl, m-terphenyl-3-yl and m-terphenyl-2-yl; the naphthyl group includes a 1-naphthyl group or a 2-naphthyl group; the anthracene group is selected from 1-anthracene group, 2-anthracene group and 9-anthracene group; the fluorenyl group is selected from the group consisting of 1-fluorenyl, 2-fluorenyl, 3-fluorenyl, 4-fluorenyl, and 9-fluorenyl; the pyrenyl group is selected from 1-pyrenyl, 2-pyrenyl and 4-pyrenyl; the tetracene group is selected from the group consisting of 1-tetracene, 2-tetracene, and 9-tetracene. C6-C30 arylene is similar to C6-C30 aryl, provided that the above groups are changed to the corresponding subunits.
In the present specification, heteroaryl includes the concept of monocyclic heteroaryl and fused heteroaryl, and examples of the heteroaryl group of C3 to C30 include: nitrogen-containing heteroaryl, oxygen-containing heteroaryl, sulfur-containing heteroaryl, and the like, and specific examples thereof include: pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, quinolyl, isoquinolyl, naphthyridinyl, phthalazinyl, quinoxalinyl, quinazolinyl, phenanthridinyl, acridinyl, phenanthrolinyl, pyrrolyl, imidazolyl, pyrazolyl, triazolyl, tetrazolyl, indolyl, benzimidazolyl, indazolyl, imidazopyridinyl, benzotriazolyl, carbazolyl, furyl, thienyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, thiadiazolyl, benzofuranyl, benzothienyl, benzoxazolyl, benzothiazolyl, benzisoxazolyl, benzisothiazolyl, benzoxadiazolyl, benzothiadiazolyl, dibenzofuranyl, dibenzothienyl, piperidyl, pyrrolidinyl, piperazinyl, morpholinyl, phenazinyl, phenothiazinyl, phenoxazinyl, and the like are preferred among them, pyridyl, dibenzofuranyl, piperidyl, pyrrolidinyl, piperazinyl, morpholinyl, phenazinyl, phenothiazinyl, phenoxazinyl, and the like, Dibenzothienyl radical.
Specific examples of the arylene group in the present invention include divalent groups obtained by removing one hydrogen atom from the above-mentioned examples of the aryl group. Specific examples of the heteroarylene group in the present invention include divalent groups obtained by removing one hydrogen atom from the above-mentioned examples of the heteroaryl group.
Examples of the aryloxy group in the present invention include monovalent groups composed of the above aryl group, heteroaryl group and oxygen.
Examples of the C6-C30 arylamino group in the present invention include: phenylamino, methylphenylamino, naphthylamino, anthrylamino, phenanthrylamino, biphenylamino and the like.
Examples of the heteroarylamino group having C3 to C30 in the present invention include: pyridylamino, pyrimidylamino, dibenzofuranylamino and the like.
In the present specification, examples of the C1-C12 alkyl group include: methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecane, dodecane, and the like, wherein methyl, ethyl, n-propyl, isopropyl, tert-butyl, sec-butyl, isobutyl, isopentyl, and methyl are preferred.
In the present specification, examples of the C1 to C12 alkoxy group include: methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, tert-butoxy, pentyloxy, isopentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy and the like, among which methoxy, ethoxy, n-propoxy, isopropoxy, tert-butoxy, sec-butoxy, isobutyloxy, isopentyloxy, more preferably methoxy, are preferred.
In the present specification, examples of the cycloalkyl group having from C3 to C12 include: cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like, with cyclopropyl being preferred.
The boron-containing organic compound of the present invention preferably has a structure represented by (2):
Figure BDA0002742689260000041
wherein, X1~X6Each independently selected from CReOr N, and Y1~Y3Each independently selected from CRfOr N;
Reand RfEach independently selected from hydrogen, halogen, cyano, hydroxyl, nitro, amino, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, substituted or unsubstituted C1-C12 alkoxy, substituted or unsubstituted C1-C12 silyl, substituted or unsubstituted C6-C30 arylamino, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3 cycloalkyl, substituted or unsubstituted C1-C12 alkoxy, substituted or unsubstituted C388 silyl, substituted or unsubstituted C6-C3526 aryl, and substituted or unsubstituted COr one of unsubstituted C3-C30 heteroaryl amino, substituted or unsubstituted C6-C30 aryl and substituted or unsubstituted C3-C30 heteroaryl;
R1and R2Each independently selected from one of hydrogen, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl.
In the boron-containing organic compound, the tension is lower when the ring X, the ring Y and the ring Z are six-membered rings respectively, and the molecular stability is better.
The boron-containing organic compound of the present invention preferably has a structure represented by (3):
Figure BDA0002742689260000051
wherein R isa、RbAnd RnRepresents one substituent group to the maximum permissible substituent group, and is respectively and independently selected from hydrogen, halogen, cyano, hydroxyl, nitro, amino, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, substituted or unsubstituted C1-C12 alkoxy, substituted or unsubstituted C1-C12 silyl, substituted or unsubstituted C6-C30 arylamino, substituted or unsubstituted C3-C30 heteroarylamino, substituted or unsubstituted C6-C30 aryl and substituted or unsubstituted C3-C30 heteroaryl;
R1and R2Each independently selected from one of substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl;
Ar1at least one position ortho to the linking position of the N atom and Ar2At least one position ortho to the position of attachment to the N atom is independently substituted with a group selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 heteroarylIs substituted by one of the above.
In the invention, groups with certain steric hindrance effect such as alkyl or halogen are simultaneously introduced on two aromatic rings (corresponding to X and Y in the formula (1)) which form a ring with the B atom, so that the conjugation of the molecule can be further effectively reduced, the sublimation temperature is further reduced, and the emission wavelength of the molecule is further blue-shifted.
Among the above boron-containing organic compounds of the present invention, Ar is preferred1At least one position ortho to the linking position of the N atom and Ar2At least one position ortho to the connecting position with the N atom is independently substituted by one selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl and substituted or unsubstituted C3-C30 heteroaryl, preferably independently substituted by substituted or unsubstituted C1-C12 alkyl, halogen or phenyl, more preferably substituted by methyl.
The invention is further directed to Ar attached to the N atom1And Ar2Meanwhile, a group with a certain steric hindrance effect is introduced, so that the conjugation of molecules can be further reduced, the blue shift of the emission wavelength of the molecules is realized, the vibration and rotation of the molecules are inhibited, and the luminous efficiency is improved.
The boron-containing organic compound of the present invention is more preferably represented by the structure (4):
Figure BDA0002742689260000061
wherein R iscAnd RdIndependently represent a single substituent to the maximum permissible substituent, each independently selected from one of hydrogen, halogen, cyano, hydroxyl, nitro, amino, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, substituted or unsubstituted C1-C12 alkoxy, substituted or unsubstituted C1-C12 silyl, substituted or unsubstituted C6-C30 arylamino, substituted or unsubstituted C3-C30 heteroarylamino, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl;
R1~R4each independently selected from one of substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl, preferably each independently selected from substituted or unsubstituted C1-C12 alkyl, halogen or phenyl, more preferably methyl, is beneficial to blue shift of light color and increase of luminous efficiency. When R in the invention is1~R4When the organic silicon compound is steric hindrance groups, the molecules are higher in rigidity and higher in luminous efficiency.
In the above boron-containing organic compound of the present invention, Ra、Rb、Rc、Rd、Re、RfAnd RnEach independently selected from hydrogen, substituted or unsubstituted C1-C12 alkyl, or substituted or unsubstituted C3-C12 cycloalkyl, preferably each independently selected from hydrogen or a substituted or unsubstituted one of the following structures:
Figure BDA0002742689260000062
more preferably Ra、Rb、Rc、Rd、Re、RfAnd RnEach independently selected from hydrogen, methyl or tert-butyl, especially Ra、RbHas good photochromic effect when hydrogen is used, and is beneficial to prolonging the service life of the device.
By adding Ra、Rb、Rc、Rd、Re、RfAnd RnOne or more of the above-mentioned groups can be preferably selected so that the size of the introduced group is more suitable, and the generated steric hindrance effect is more favorable for lowering the sublimation temperature and blue-shifting the emission wavelength of the molecule.
The above-mentioned compounds of the present invention are preferably selected from the structures represented by the following M1 to M101, but these compounds are merely representative:
Figure BDA0002742689260000071
Figure BDA0002742689260000081
Figure BDA0002742689260000091
Figure BDA0002742689260000101
the invention also relates to the application of the boron-containing organic compound in an organic electroluminescent device. The above boron-containing organic compound may be used as, but not limited to, a light-emitting layer material in an organic electroluminescent device.
The present invention also provides an organic electroluminescent device comprising a first electrode, a second electrode and a plurality of organic layers interposed between the first electrode and the second electrode, characterized in that at least one of the organic layers contains the above-mentioned compound of the present invention.
Effects of the invention
According to the invention, groups with certain steric hindrance effect, such as alkyl or halogen, are introduced on the aromatic ring which is in ring formation with the B atom and at the ortho-position of the aromatic ring connected with the N atom, so that the conjugation of molecules can be effectively reduced, the sublimation temperature is reduced, and simultaneously the light color of the material can be adjusted, so that the emission wavelength of the molecules is blue-shifted.
Detailed Description
In order to make those skilled in the art better understand the present invention, the following will describe the specific preparation method of the above compound of the present invention by taking several synthetic examples as examples, but the preparation method of the present invention is not limited to these several synthetic examples, and those skilled in the art can make any modification, equivalent substitution, improvement, etc. without departing from the principle of the present invention, and extend the method to the scope of the technical scheme of the present invention as claimed in the claims.
Solvents and reagents used in the preparation method of the present invention, such as methylene chloride, petroleum ether, ethanol, tetrahydrofuran, N-dimethylacetamide, anhydrous magnesium sulfate, carbazole, benzimidazole, and other chemical reagents, can be purchased from domestic chemical product markets, such as from national drug group reagent company, TCI company, shanghai bibi pharmaceutical company, carbofuran reagent company, and the like. The compounds of the synthetic processes not mentioned in the present invention are either starting products obtained commercially or are prepared by these starting products according to known methods. Analytical testing of intermediates and compounds in the present invention uses an abciex mass spectrometer (4000 QTRAP).
Synthesis example 1: synthesis of Compound M1
Figure BDA0002742689260000111
Synthesis of intermediate M1-1:
to a 2L single-neck flask was added 2-bromotoluene (50g, 292mmol), 2-bromoaniline (37.6g, 351mmol), Pd (dppf) Cl at room temperature2(4.4g, 6mmol), S-Phos (4.9g, 12mmol), sodium t-butoxide (38.4g, 400mmol) and 1200mL of dry toluene were purged with nitrogen 3 times and then heated under reflux overnight. After the reaction had ended, the reaction mixture was washed with copious amounts of water, the organic phases were combined and dried, concentrated and chromatographed (PE: DCM 100: 1) to give 45g of the product as a pale yellow oil. Mass spectrometric analysis determined molecular ion mass: 197.12 (theoretical value: 197.12).
Synthesis of intermediate M1-2:
m1-1(9.8g, 50mmol), M-dibromobenzene (4.7g, 20mmol), Pd were added at room temperature2(dba)3(0.43g, 0.47mmol), s-Phos (0.38g, 0.94mmol), sodium t-butoxide (6.8g, 70mmol), xylene (200ml) were charged in a 500ml single-necked flask, replaced with nitrogen three times, and heated to 130 ℃ for reaction overnight. The reaction mixture is cooled to room temperature, extracted with ethyl acetate, washed with copious amounts of water, the organic phase is dried and concentrated by column chromatography (PE: DCM 50: 1) to give 8.5g of a white solid. Mass spectrometric analysis determined molecular ion mass: 468.26 (theoretical value):468.26)。
Synthesis of compound M1:
m1-2(4.7g, 10mmol) was added to a 500ml three-necked flask, p-tert-butylbenzene (100ml) was added, the reaction system was cooled to-20 ℃ after stirring for 20 minutes, 15mmol of tert-butyllithium was added, and stirring was continued for 30 minutes while maintaining the low temperature. Then gradually heating to 90 ℃, and continuously heating for 3 h. Finally, the temperature of the reaction system is reduced to minus 20 ℃ again, boron tribromide (5.1g, 20mmol) is added under the protection of nitrogen, and diisopropylethylamine (13g, 80mmol) is added after stirring for 30 minutes. Finally, the reaction system is heated to 110 ℃ and reacted for 12 h. After the reaction was cooled to room temperature, the organic phase was spin-dried under reduced pressure. Ethyl acetate (200ml) was extracted three times, and the organic phases were combined and dried over anhydrous sodium sulfate. The organic phase is concentrated with silica gel and chromatographed (PE: DCM 100: 1) to give 2.8g of crude product, which is recrystallized from toluene/n-hexane to give 1.0g of a yellow solid. Mass spectrometric analysis determined molecular ion mass: 476.24 (theoretical value: 476.24).
Synthesis example 2: synthesis of Compound M22
The synthesis method is similar to that of M1, except that M-dibromobenzene in the second step is changed into 1, 3-dibromo-5-tert-butylbenzene, and finally column chromatography is carried out to obtain 2.6g of light yellow crude product, and then 0.8g of yellow solid M29 is obtained by recrystallization from toluene/n-hexane. Mass spectrometric analysis determined molecular ion mass: 532.32 (theoretical value: 532.30).
Synthesis example 3: synthesis of Compound M66
Figure BDA0002742689260000121
Synthesis of intermediate M66-1:
m1-1(13.8g, 70mmol), tribromobenzene (6.2g, 20mmol), Pd was added at room temperature2(dba)3(0.55g, 0.6mmol), s-Phos (0.49g, 1.2mmol), sodium t-butoxide (7.7g, 80mmol), xylene (250ml) were added to a 500ml single-neck flask, replaced with nitrogen three times, and heated to 130 ℃ for reaction overnight. Cooling the reaction solution to room temperature, extracting with ethyl acetate, washing with a large amount of water, and preparing an organic solutionAfter drying, the phases are concentrated and subjected to column chromatography (PE: DCM ═ 20: 1) to give 11.5g of crude product, which is recrystallized from toluene/ethanol to give 9.4g of a white solid. Mass spectrometric analysis determined molecular ion mass: 663.36 (theoretical value: 663.36).
Synthesis of compound M66:
m66-1(6.6g, 10mmol) was added to a 500ml three-necked flask, p-tert-butylbenzene (100ml) was added, the reaction system was cooled to-20 ℃ after stirring for 20 minutes, 15mmol of tert-butyllithium was added, and stirring was continued for 30 minutes while maintaining the low temperature. Then gradually heating to 90 ℃ and continuously heating for 3 h. Finally, the temperature of the reaction system is reduced to-20 ℃ again, boron tribromide (5.1g, 20mmol) is added under the protection of nitrogen, and diisopropylethylamine (13g, 80mmol) is added after stirring for 30 minutes. Finally, the reaction system is heated to 110 ℃ and reacted for 12 h. After the reaction was cooled to room temperature, the organic phase was spin-dried under reduced pressure. Ethyl acetate (200ml) was extracted three times, and the organic phases were combined and dried over anhydrous sodium sulfate. The organic phase is concentrated with silica gel and chromatographed (PE: DCM 50: 1) to give 3.8g of crude product, which is recrystallized from toluene/n-hexane to give 1.4g of a yellow solid. Mass spectrometric analysis determined molecular ion mass: 671.35 (theoretical value: 671.35).
Device embodiments
The present invention also provides an organic electronic light emitting device comprising the above-described example compound. An example of using an OLED as an embodiment of the organic electronic light emitting device is illustrated below. The OLED of the present embodiment includes first and second electrodes, and an organic material layer between the electrodes. The organic material may in turn be divided into a plurality of regions. For example, the organic material layer may include a hole transport region, a light emitting layer, and an electron transport region.
In a specific embodiment, a substrate may be used below the first electrode or above the second electrode. The substrate is a glass or polymer material having excellent mechanical strength, thermal stability, water resistance, and transparency. In addition, a Thin Film Transistor (TFT) may be provided on a substrate for a display.
The first electrode may be formed by sputtering or depositing a material used as the first electrode on the substrate. When the first electrode is used as an anode, an oxide transparent conductive material such as Indium Tin Oxide (ITO), Indium Zinc Oxide (IZO), tin dioxide (SnO2), zinc oxide (ZnO), or any combination thereof may be used. When the first electrode is used as a cathode, a metal or an alloy such as magnesium (Mg), silver (Ag), aluminum (Al), aluminum-lithium (Al-Li), calcium (Ca), ytterbium (Yb), magnesium-indium (Mg-In), magnesium-silver (Mg-Ag), or any combination thereof can be used.
The organic material layer may be formed on the electrode by vacuum thermal evaporation, spin coating, printing, or the like. The compound used as the organic material layer may be an organic small molecule, an organic large molecule, and a polymer, and a combination thereof.
The hole transport region is located between the anode and the light emitting layer. The hole transport region may be a Hole Transport Layer (HTL) of a single layer structure including a single layer containing only one compound and a single layer containing a plurality of compounds. The hole transport region may also be a multilayer structure including at least one of a Hole Injection Layer (HIL), a Hole Transport Layer (HTL), and an Electron Blocking Layer (EBL).
The material of the hole transport region may be selected from, but is not limited to, phthalocyanine derivatives such as CuPc, conductive polymers or polymers containing conductive dopants such as polyphenylenevinylene, polyaniline/dodecylbenzenesulfonic acid (Pani/DBSA), poly (3, 4-ethylenedioxythiophene)/poly (4-styrenesulfonate) (PEDOT/PSS), polyaniline/camphorsulfonic acid (Pani/CSA), polyaniline/poly (4-styrenesulfonate) (Pani/PSS), aromatic amine derivatives such as compounds shown below in HT-1 to HT-51; or any combination thereof.
Figure BDA0002742689260000131
Figure BDA0002742689260000141
Figure BDA0002742689260000151
Figure BDA0002742689260000161
The hole injection layer is located between the anode and the hole transport layer. The hole injection layer may be a single compound material or a combination of a plurality of compounds. For example, the hole injection layer may employ one or more compounds of HT-1 to HT-51 described above, or one or more compounds of HI1-HI3 described below; one or more of the compounds HT-1 to HT-51 may also be used to dope one or more of the compounds HI1-HI3 described below.
Figure BDA0002742689260000162
In one aspect of the invention, the light-emitting layer employs a fluorescent electroluminescence technique. The luminescent layer fluorescent host material may be selected from, but not limited to, the combination of one or more of BFH-1 through BFH-17 listed below.
Figure BDA0002742689260000163
In one aspect of the invention, the light-emitting layer employs a thermally activated delayed fluorescence emission technique. The host material of the light-emitting layer is selected from, but not limited to, one or more of the combinations of PH-1 to PH-85.
Figure BDA0002742689260000171
Figure BDA0002742689260000181
Figure BDA0002742689260000191
Figure BDA0002742689260000201
In one aspect of the invention, the light-emitting layer employs a thermally activated delayed fluorescence emission technique. The fluorescent dopant of the light-emitting layer can be selected from, but is not limited to, one or more of TDE1-TDE37 listed below.
Figure BDA0002742689260000202
Figure BDA0002742689260000211
In one aspect of the invention, an Electron Blocking Layer (EBL) is located between the hole transport layer and the light emitting layer. The electron blocking layer may be, but is not limited to, one or more compounds of HT-1 to HT-51 described above, or one or more compounds of PH-47 to PH-77 described above; mixtures of one or more compounds from HT-1 to HT-51 and one or more compounds from PH-47 to PH-77 may also be used, but are not limited thereto.
The OLED organic material layer may further include an electron transport region between the light emitting layer and the cathode. The electron transport region may be an Electron Transport Layer (ETL) of a single-layer structure including a single-layer electron transport layer containing only one compound and a single-layer electron transport layer containing a plurality of compounds. The electron transport region may also be a multilayer structure including at least one of an Electron Injection Layer (EIL), an Electron Transport Layer (ETL), and a Hole Blocking Layer (HBL).
In one aspect of the invention, the electron transport layer material may be selected from, but is not limited to, the combination of one or more of ET-1 through ET-65 listed below.
Figure BDA0002742689260000221
Figure BDA0002742689260000231
Figure BDA0002742689260000241
In one aspect of the invention, a Hole Blocking Layer (HBL) is located between the electron transport layer and the light emitting layer. The hole blocking layer can adopt, but is not limited to, one or more compounds of ET-1 to ET-65 or one or more compounds of PH-1 to PH-46; mixtures of one or more compounds from ET-1 to ET-65 with one or more compounds from PH-1 to PH-46 may also be used, but are not limited thereto.
An electron injection layer may also be included in the device between the electron transport layer and the cathode, the electron injection layer materials including, but not limited to, combinations of one or more of the following.
LiQ,LiF,NaCl,CsF,Li2O,Cs2CO3,BaO,Na,Li,Ca,Yb,Mg。
The effect of the synthesized boron-containing organic compound of the present invention as a material for a light emitting layer in a device is described in detail by examples 1 to 5 and comparative examples 1 to 2 below.
The fabrication of device example 1 was as follows:
the glass plate coated with the ITO transparent conductive layer was sonicated in a commercial detergent, rinsed in deionized water, washed in acetone: ultrasonically removing oil in an ethanol mixed solvent, baking in a clean environment until the water is completely removed, cleaning by using ultraviolet light and ozone, and bombarding the surface by using low-energy cationic beams;
placing the glass substrate with the anode in a vacuum chamber, and vacuumizing to less than 1 × 10-5Pa, performing vacuum thermal evaporation on the anode layer film in sequence to obtain a 10nm HT-4: HI-3(97/3, w/w) mixture as a hole injection layer, a 60nm compound HT-4 as a hole transport layer and a 5nm compound HT-14 as an electron blocking layer; a binary mixture of 20nm compounds BFH-4: M1 (100: 3, w/w) as a luminescent layer, wherein M1 is a luminescent dye(ii) a ET-23 at 5nm as hole blocking layer, ET-61: ET-57(50/50, w/w) mixture of compounds at 25nm as electron transport layer, LiF at 1nm as electron injection layer, and metallic aluminum at 150nm as cathode. The total evaporation rate of all the organic layers and LiF is controlled at 0.1 nm/s, and the evaporation rate of the metal electrode is controlled at 1 nm/s.
Examples 2 to 15 and comparative examples 1 to 2
Examples 2 to 15 and comparative examples 1 to 2 were fabricated by the same procedure as in example 1 except that the light-emitting dye M1 in the light-emitting layer was replaced with the corresponding compound in table 1, respectively, to give organic electroluminescent devices of examples 2 to 15 and comparative examples 1 to 2.
Wherein the structural formulas of C1 and C2 are as follows:
Figure BDA0002742689260000251
the organic electroluminescent device prepared by the above process was subjected to the following performance measurement:
the current efficiencies of the organic electroluminescent devices prepared in examples 1 to 15 and comparative examples 1 to 2 were measured at the same luminance using a digital source meter and a luminance meter. Specifically, the voltage was raised at a rate of 0.1V per second, and it was determined that the luminance of the organic electroluminescent device reached 1000cd/m2Current density of time; the ratio of the luminance to the current density is the current efficiency.
TABLE 1
Figure BDA0002742689260000261
As can be seen from Table 1, when the compounds of examples 1 to 15 of the device of the present invention were used as dyes, the emission wavelength was blue-shifted, the efficiency was improved, and excellent device properties were exhibited, as compared with the compounds of comparative examples 1 to 2 of the device. The principle is not clear, but the following is presumed: compared with the compounds of comparative examples 1-2 of devices, because the compounds of the invention introduce alkyl equipotential groups at specific positions, the conjugation degree of molecules is reduced, the blue shift of emission spectrum is realized, and meanwhile, the vibration rotation of molecules is inhibited, and the luminous efficiency is improved, which is beneficial to the practical application of the compounds of the invention.
Furthermore, the inventors have found that examples 5, 9, 11, and 12 have slightly lower blue-shift of the emission spectra than other examples, and the difference between them is mainly that: in the compounds of examples 5, 9, 11, 12, steric hindrance groups were simultaneously introduced into ortho positions of two benzene rings to which only one N atom was bonded, and it was thus presumed that: in the compound represented by the formula (3) of the present invention, R1~R4All the steric hindrance groups are more favorable for improving the blue shift degree of an emission spectrum.
The inventors also found that the compound of example 14, when used as a dye, has a lower current efficiency and a lower degree of blue shift than the compound of example 1, and the principle thereof is not clear, but the following is presumed: in the compound of example 1, the aromatic ring forming a ring with an N atom is a benzene ring, while in the compound of example 14, the corresponding is a pyridine ring, and thus it is inferred that: in the compound represented by the formula (1), when ring X or ring Y is a benzene ring, it is more advantageous for improving the luminous efficiency and the degree of blue shift.
It should be understood that the above examples are only for clarity of illustration and are not intended to limit the embodiments. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. And obvious variations or modifications therefrom are within the scope of the invention.

Claims (10)

1. A boron-containing organic compound characterized by having a structure represented by (1):
Figure FDA0002742689250000011
wherein, ring X, ring Y and ring Z are each independently selected from a substituted or unsubstituted 6-to 30-membered aromatic ring or a substituted or unsubstituted 4-to 30-membered aromatic heterocyclic ring, preferably a substituted or unsubstituted 6-to 8-membered aromatic ring or a substituted or unsubstituted 6-to 8-membered aromatic heterocyclic ring, more preferably a substituted or unsubstituted benzene or a substituted or unsubstituted 6-membered aromatic heterocyclic ring;
when the ring X, the ring Y or the ring Z has a substituent, the substituent is selected from one of halogen, cyano, hydroxyl, nitro, amino, substituted or unsubstituted C1 to C12 alkyl, substituted or unsubstituted C3 to C12 cycloalkyl, substituted or unsubstituted C1 to C12 alkoxy, substituted or unsubstituted C1 to C12 silyl, substituted or unsubstituted C6 to C30 arylamino, substituted or unsubstituted C3 to C30 heteroarylamino, substituted or unsubstituted C6 to C30 aryl, and substituted or unsubstituted C3 to C30 heteroaryl;
Ar1~Ar2each independently selected from one of substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted C3-C30 heteroaryl;
and the following conditions are satisfied: at Ar1、Ar2In ring X and ring Y, Ar1At least one position ortho to the linking site of the N atom and ortho to the linking site of the ring X and the N atom, and/or, Ar2At least one position ortho to the linking position with the N atom and ortho to the linking position of ring Y with the N atom is substituted with one selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl;
when the substituted or unsubstituted group has a substituent, the substituent is selected from one or a combination of at least two of halogen, cyano, hydroxyl, nitro, amino, C1-C12 alkyl, C3-C12 cycloalkyl, C1-C12 alkoxy, C1-C12 silyl, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryl, and C3-C30 heteroaryl.
2. The boron-containing organic compound according to claim 1, wherein the boron-containing organic compound has a structure represented by (2):
Figure FDA0002742689250000021
wherein, X1~X6Each independently selected from CReOr N, and Y1~Y3Each independently selected from CRfOr N;
Reand RfEach independently selected from one of hydrogen, halogen, cyano, hydroxyl, nitro, amino, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, substituted or unsubstituted C1-C12 alkoxy, substituted or unsubstituted C1-C12 silyl, substituted or unsubstituted C6-C30 arylamino, substituted or unsubstituted C3-C30 heteroarylamino, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl;
R1and R2Each independently selected from one of hydrogen, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl.
3. The boron-containing organic compound according to claim 1 or 2, wherein the boron-containing organic compound has a structure represented by (3):
Figure FDA0002742689250000022
wherein R isa、RbAnd RnRepresents one substituent group to the maximum permissible substituent group, and is respectively and independently selected from hydrogen, halogen, cyano, hydroxyl, nitro, amino, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, substituted or unsubstituted C1-C12 alkoxy, substituted or unsubstituted C1-C12 silyl, substituted or unsubstituted C6-C30 arylamino, substituted or unsubstituted C3-C30 heteroarylamino, substituted or unsubstituted C6-C30 aryl and substituted or unsubstituted C3-C30 heteroaryl;
R1and R2Each independently selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl;
Ar1at least one position ortho to the linking position of the N atom and Ar2At least one position ortho to the connecting position with the N atom is independently substituted by one selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl and substituted or unsubstituted C3-C30 heteroaryl.
4. The boron-containing organic compound according to claim 1 or 2, wherein Ar is Ar1At least one position ortho to the linking position of the N atom and Ar2At least one position ortho to the connecting position with the N atom is independently substituted by one selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl and substituted or unsubstituted C3-C30 heteroaryl, preferably independently substituted by substituted or unsubstituted C1-C12 alkyl, halogen or phenyl, more preferably substituted by methyl.
5. The boron-containing organic compound of claim 3, wherein R isa、RbAnd RnEach independently selected from hydrogen, substituted or unsubstituted C1-C12 alkyl, or substituted or unsubstituted C3-C12 cycloalkyl, preferably each independently selected from hydrogen or a substituted or unsubstituted one of the following structures:
Figure FDA0002742689250000031
more preferably Ra、RbAnd RnEach independently selected from hydrogen, methyl or tert-butyl.
6. The boron-containing organic compound according to claim 1 or 2, wherein the boron-containing organic compound has a structure represented by (4):
Figure FDA0002742689250000032
wherein R isa、Rb、Rn、RcAnd RdIndependently represent a single substituent to the maximum permissible substituent, each independently selected from one of hydrogen, halogen, cyano, hydroxyl, nitro, amino, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, substituted or unsubstituted C1-C12 alkoxy, substituted or unsubstituted C1-C12 silyl, substituted or unsubstituted C6-C30 arylamino, substituted or unsubstituted C3-C30 heteroarylamino, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl;
R1~R4each independently selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 cycloalkyl, halogen, substituted or unsubstituted C6-C30 aryl, and substituted or unsubstituted C3-C30 heteroaryl, preferably each independently selected from substituted or unsubstituted C1-C12 alkyl, halogen, or phenyl, more preferably methyl.
7. The boron-containing organic compound of claim 6, wherein R isa、Rb、Rc、RdAnd RnEach independently selected from hydrogen, substituted or unsubstituted C1-C12 alkyl, or substituted or unsubstituted C3-C12 cycloalkyl, preferably Ra、Rb、Rc、RdAnd RnEach independently selected from hydrogen or a substituted or unsubstituted one of the following structures:
Figure FDA0002742689250000041
more preferably Ra、Rb、Rc、RdAnd Rn are each independently selected from hydrogen, methyl or tert-butyl, further preferably Ra、Rb、Rc、RdAnd RnIs hydrogen.
8. The boron-containing organic compound according to claim 1, wherein the boron-containing organic compound has a structure represented by M1 to M101:
Figure FDA0002742689250000042
Figure FDA0002742689250000051
Figure FDA0002742689250000061
Figure FDA0002742689250000071
Figure FDA0002742689250000081
9. use of the boron-containing organic compound according to any one of claims 1 to 8 in an organic electroluminescent device.
10. An organic electroluminescent device comprising a first electrode, a second electrode and an organic layer interposed between the first electrode and the second electrode, characterized in that the organic layer contains the boron-containing organic compound according to any one of claims 1 to 8.
CN202011160022.6A 2020-10-26 2020-10-26 Boron-containing organic compound and organic electroluminescent device containing same Pending CN114478593A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011160022.6A CN114478593A (en) 2020-10-26 2020-10-26 Boron-containing organic compound and organic electroluminescent device containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011160022.6A CN114478593A (en) 2020-10-26 2020-10-26 Boron-containing organic compound and organic electroluminescent device containing same

Publications (1)

Publication Number Publication Date
CN114478593A true CN114478593A (en) 2022-05-13

Family

ID=81470864

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011160022.6A Pending CN114478593A (en) 2020-10-26 2020-10-26 Boron-containing organic compound and organic electroluminescent device containing same

Country Status (1)

Country Link
CN (1) CN114478593A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024088326A1 (en) * 2022-10-28 2024-05-02 华为技术有限公司 Organic compound and use thereof
WO2024185710A1 (en) * 2023-03-03 2024-09-12 出光興産株式会社 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024088326A1 (en) * 2022-10-28 2024-05-02 华为技术有限公司 Organic compound and use thereof
WO2024185710A1 (en) * 2023-03-03 2024-09-12 出光興産株式会社 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device

Similar Documents

Publication Publication Date Title
CN112898322A (en) Organic compound, application thereof and organic electroluminescent device containing organic compound
CN112679531A (en) Boron-containing compound and organic electroluminescent device containing same
CN112614953B (en) Organic electroluminescent device and display device
CN115477587A (en) Organic compound, application thereof and organic electroluminescent device comprising organic compound
CN114171692A (en) Organic electroluminescent device and display device
CN112614952A (en) Organic electroluminescent device and display device
CN112174968A (en) Organic compound for light-emitting device, application thereof, and organic electroluminescent device
CN114106022A (en) Organic compound for organic electroluminescent device and organic electroluminescent device
CN114478593A (en) Boron-containing organic compound and organic electroluminescent device containing same
CN113024510A (en) Indole derivative and application thereof
CN112851698A (en) Boron-containing compound and organic electroluminescent device using same
CN113173935B (en) Compound and application thereof
CN112614954B (en) Organic light-emitting device and display device
CN112490382B (en) Organic light-emitting device and display device
CN114478592A (en) Boron-containing organic compound and organic electroluminescent device containing same
CN112430230B (en) Organic compound and organic electroluminescent device containing the same
CN114539297A (en) Boron-containing compound, application thereof and organic electroluminescent device
CN114685354A (en) Organic compound, application thereof and organic electroluminescent device comprising organic compound
CN115160342A (en) Compound, application thereof and organic electroluminescent device comprising compound
CN114105785A (en) Organic compound for organic electroluminescent device, application of organic compound and organic electroluminescent device
CN114685411A (en) Organic compound, application thereof and organic electroluminescent device
CN113880869A (en) Compound, application thereof and organic electroluminescent device comprising compound
CN113880848A (en) Compound, application thereof and organic electroluminescent device comprising compound
CN113929646A (en) Organic compound and organic electroluminescent device
CN113620817A (en) Compound and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination